Cytek BioSciences Inc’s recently made public that its CHIEF TECHNOLOGY OFFICER Yan Ming unloaded Company’s shares for reported $13304.0 on Apr 09 ’24. In the deal valued at $7.00 per share,1,900 shares were sold. As a result of this transaction, Yan Ming now holds 6,008,502 shares worth roughly $36.17 million.
Then, Yan Ming sold 20,000 shares, generating $134,200 in total proceeds. Upon selling the shares at $6.71, the CHIEF TECHNOLOGY OFFICER now owns 6,010,402 shares.
Before that, Yan Ming sold 20,000 shares. Cytek BioSciences Inc shares valued at $135,400 were divested by the CHIEF TECHNOLOGY OFFICER at a price of $6.77 per share. As a result of the transaction, Yan Ming now holds 6,030,402 shares, worth roughly $36.3 million.
Stephens initiated its Cytek BioSciences Inc [CTKB] rating to an Overweight in a research note published on December 14, 2023; the price target was $9. A number of analysts have revised their coverage, including Raymond James’s analysts, who began to cover the stock in mid July with a ‘”a Mkt perform”‘ rating.
Price Performance Review of CTKB
On Monday, Cytek BioSciences Inc [NASDAQ:CTKB] saw its stock fall -2.43% to $6.02. Over the last five days, the stock has lost -10.15%. Cytek BioSciences Inc shares have fallen nearly -33.99% since the year began. Nevertheless, the stocks have fallen -41.55% over the past one year. While a 52-week high of $12.31 was reached on 03/04/24, a 52-week low of $3.80 was recorded on 04/15/24. SMA at 50 days reached $7.40, while 200 days put it at $7.36. A total of 1.39 million shares were traded, compared to the trading of 0.47 million shares in the previous session.
Levels Of Support And Resistance For CTKB Stock
The 24-hour chart illustrates a support level at 5.84, which if violated will result in even more drops to 5.65. On the upside, there is a resistance level at 6.24. A further resistance level may holdings at 6.45. The Relative Strength Index (RSI) on the 14-day chart is 34.96, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.32, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.96%. Stochastics %K at 11.63% indicates the stock is a buying.
